IDH1 and brain neoplasm: This study has begun to explain how differentiation therapy may benefit the treatment of IDH mutant brain tumours, as it removes the 2-HG-dependent hypermethylation phenotype and alters the expression of a wide range of genes, which may enable differentiation of the cells.